<section class="ondra-article-page"> <div class="ondra-article-hero"> <div class="ondra-article-container"> <div class="ondra-article-meta-row"><span class="ondra-meta-pill">⏱ 8 min read</span><span class="ondra-meta-pill">Updated July 2026</span></div> <h1 class="ondra-article-title">Maintenance and Stopping: What Happens When You Reach Your Goal</h1> <p class="ondra-article-intro">Reaching your goal weight raises a question the early months don't: what now? Do you stay on the medication, move to a lower maintenance dose, or stop? This guide covers what maintenance looks like, what the research shows about stopping, and how to approach the decision with your provider. This is one of the most consequential decisions in GLP-1 treatment, and it belongs with a licensed provider rather than being made alone.</p> </div> </div> <div class="ondra-article-container ondra-article-body"> <div class="ondra-article-layout" id="ondraArticleLayout"> <div class="ondra-article-main" id="ondraArticleMain"> <a href="/blog" class="ondra-back-link">← Back to all articles</a> <div class="ondra-takeaways-card"> <h2 class="ondra-card-heading">Key takeaways</h2> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Reaching your goal isn't automatically the end of treatment. Maintenance is a legitimate phase with its own plan.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Clinical trial data shows meaningful weight regain after stopping tirzepatide, and better maintenance among those who continued.</p></div> <div class="ondra-takeaway-item"><span class="ondra-check"><svg width="16" height="16" viewBox="0 0 16 16" fill="none"><circle cx="8" cy="8" r="7" stroke="currentColor" stroke-width="1.4"/><path d="M4.5 8.5L6.5 10.5L11.5 5.5" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></span><p>Whether to continue, reduce, or stop is a clinical decision — discuss it with your provider rather than stopping abruptly.</p></div> </div> <div class="ondra-section"> <h2>What does maintenance mean?</h2> <p>Maintenance is the phase after you've reached the weight you were aiming for, where the goal shifts from losing to holding. In practice that can look like continuing at your current dose, moving to a lower dose that maintains your results, or in some cases stopping under a provider's guidance.</p> <p>Which of these fits you depends on your health profile, how you've responded, and your goals — which is why it's a conversation with your provider at Wasef Health, PC rather than a default that applies to everyone.</p> </div> <div class="ondra-section"> <h2>What does the research show about stopping?</h2> <p>The SURMOUNT-4 trial (Aronne et al., JAMA, 2023) studied what happens when tirzepatide is continued versus withdrawn after an initial lead-in period. After the lead-in, participants who continued tirzepatide saw a further <strong>5.5% reduction</strong> from week 36 to week 88, while those switched to placebo <strong>regained 14.0%</strong> over the same period.</p> <div class="ondra-info-card"> <p class="ondra-info-title">Total results over the full trial</p> <p>Across the full 88 weeks, participants who continued tirzepatide had a total mean weight reduction of <strong>25.3%</strong>, compared with <strong>9.9%</strong> among those who stopped. Additionally, <strong>89.5%</strong> of those who continued maintained at least 80% of their lead-in weight loss, versus <strong>16.6%</strong> of those who discontinued.</p> </div> <p>These findings come from trials of FDA-approved tirzepatide. Compounded medications have not been evaluated in trials of this kind. Individual results vary, and these figures describe trial populations rather than predicting what will happen for any specific person.</p> </div> <div class="ondra-section"> <h2>Why does weight often return after stopping?</h2> <p>These medications work while they're being taken — they influence appetite and how full you feel. When treatment stops, those effects fade, and appetite commonly returns toward where it was before. Combined with a body that now requires fewer calories at a lower weight, that makes regain a common outcome rather than a personal failure.</p> <p>This is why the decision to stop is worth planning rather than making impulsively during a frustrating week.</p> </div> <div class="ondra-section"> <h2>Can I stay on a lower maintenance dose?</h2> <p>For some patients, yes. A lower dose that maintains results while reducing cost or side effects can be a reasonable approach, and the "lowest effective dose" is a legitimate goal in maintenance just as it is during titration.</p> <p>Whether that's right for you, and what dose it would be, is a decision your provider makes based on your response. Message your care team through the <a href="https://care.ondra.health" target="_blank" rel="noopener">patient portal</a> to start that conversation.</p> </div> <div class="ondra-section"> <h2>What if I want to stop?</h2> <p>People stop for many legitimate reasons — cost, side effects, reaching a goal, or simply wanting to. What matters is doing it deliberately. Talk with your provider before stopping so you understand what to expect, whether tapering makes sense for you, and what a plan for holding your results might look like.</p> <p>If cost is the driver, raise that specifically. There may be plan options worth discussing — Ondra offers both monthly and quarterly billing, and quarterly carries a lower effective monthly cost — before stopping treatment entirely.</p> </div> <div class="ondra-section"> <h2>What helps hold results long term?</h2> <p>The habits that support maintenance are the same ones that support the losing phase, and they matter more once medication support changes: adequate protein intake, resistance training to preserve muscle, consistent sleep, and regular movement. Patients who build these during treatment generally have more to stand on afterward than those who relied on appetite suppression alone.</p> </div> <div class="ondra-section"> <h2>Frequently asked questions</h2> <div class="ondra-faq-item"><h3>What happens if I stop taking tirzepatide?</h3><p>In the SURMOUNT-4 trial (Aronne et al., JAMA, 2023), participants who switched to placebo after a lead-in period regained 14.0% from week 36 to week 88, while those who continued tirzepatide lost a further 5.5%. Across the full 88 weeks, continuing participants had a total reduction of 25.3% versus 9.9% for those who stopped. These findings are from trials of FDA-approved tirzepatide; individual results vary.</p></div> <div class="ondra-faq-item"><h3>Why do people regain weight after stopping a GLP-1?</h3><p>These medications work while being taken — they influence appetite and fullness. When treatment stops, those effects fade and appetite commonly returns toward its prior level. Combined with a body that needs fewer calories at a lower weight, regain is a common outcome rather than a personal failure.</p></div> <div class="ondra-faq-item"><h3>Can I switch to a lower maintenance dose?</h3><p>For some patients, yes. A lower dose that maintains results while reducing cost or side effects can be reasonable. Whether it's appropriate for you, and what that dose would be, is a decision your provider at Wasef Health, PC makes based on your response. Message your care team to discuss it.</p></div> <div class="ondra-faq-item"><h3>Should I stop treatment once I reach my goal weight?</h3><p>Not automatically — maintenance is a legitimate phase with its own plan, and options include continuing, moving to a lower dose, or stopping under guidance. Discuss it with your provider rather than stopping abruptly, so you understand what to expect.</p></div> <div class="ondra-faq-item"><h3>What helps maintain weight loss long term?</h3><p>Adequate protein, resistance training to preserve muscle, consistent sleep, and regular movement. Patients who build these habits during treatment generally have more to stand on afterward than those who relied on appetite suppression alone.</p></div> </div> <p class="ondra-disclaimer">† This article is for informational purposes only and does not constitute medical advice. Ondra Health is a telehealth platform, not a medical provider, and does not prescribe or compound medication. This content does not establish a provider-patient relationship or replace personalized guidance from a licensed professional. Clinical trial figures cited describe FDA-approved tirzepatide as studied in SURMOUNT-4 (Aronne et al., JAMA, 2023); compounded medications have not been evaluated in trials of this kind, and individual results vary. Decisions about continuing, reducing, or stopping treatment are made by licensed providers at Wasef Health, PC, an independent practice — do not stop or change your dose without provider guidance. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing.</p> </div> <aside class="ondra-article-sidebar" id="ondraSidebarCol"> <div class="ondra-sidebar-track" id="ondraSidebarTrack"> <div class="ondra-sidebar-card-wrap" id="ondraSidebarWrap"> <div class="ondra-sidebar-card" id="ondraSidebarCard"> <div class="ondra-sidebar-top"> <p class="ondra-sidebar-eyebrow">ONDRA HEALTH</p> <h3>Thinking about maintenance?</h3> </div> <div class="ondra-sidebar-bottom"> <div class="ondra-sidebar-item"><span>✔</span><p>Discuss maintenance dosing with your provider</p></div> <div class="ondra-sidebar-item"><span>✔</span><p>Monthly and quarterly plans available</p></div> <div class="ondra-sidebar-item"><span>✔</span><p>Flat pricing across all doses</p></div> <div class="ondra-sidebar-item"><span>✔</span><p>Ongoing provider support</p></div> <a href="https://care.ondra.health/login" class="ondra-sidebar-button">Message your care team <span aria-hidden="true">→</span></a> <p class="ondra-sidebar-note">Talk to your provider before stopping treatment.</p> </div> </div> </div> </div> </aside> </div> </div> </section> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What happens if I stop taking tirzepatide?","acceptedAnswer":{"@type":"Answer","text":"In the SURMOUNT-4 trial (Aronne et al., JAMA, 2023), participants who switched to placebo after a lead-in period regained 14.0% from week 36 to week 88, while those who continued tirzepatide lost a further 5.5%. Across the full 88 weeks, continuing participants had a total reduction of 25.3% versus 9.9% for those who stopped. These findings are from trials of FDA-approved tirzepatide; individual results vary."}},{"@type":"Question","name":"Why do people regain weight after stopping a GLP-1?","acceptedAnswer":{"@type":"Answer","text":"These medications work while being taken — they influence appetite and fullness. When treatment stops, those effects fade and appetite commonly returns toward its prior level. Combined with a body that needs fewer calories at a lower weight, regain is a common outcome rather than a personal failure."}},{"@type":"Question","name":"Can I switch to a lower maintenance dose?","acceptedAnswer":{"@type":"Answer","text":"For some patients, yes. A lower dose that maintains results while reducing cost or side effects can be reasonable. Whether it's appropriate for you, and what that dose would be, is a decision your provider at Wasef Health, PC makes based on your response. Message your care team to discuss it."}},{"@type":"Question","name":"Should I stop treatment once I reach my goal weight?","acceptedAnswer":{"@type":"Answer","text":"Not automatically — maintenance is a legitimate phase with its own plan, and options include continuing, moving to a lower dose, or stopping under guidance. Discuss it with your provider rather than stopping abruptly, so you understand what to expect."}},{"@type":"Question","name":"What helps maintain weight loss long term?","acceptedAnswer":{"@type":"Answer","text":"Adequate protein, resistance training to preserve muscle, consistent sleep, and regular movement. Patients who build these habits during treatment generally have more to stand on afterward than those who relied on appetite suppression alone."}}]} </script>